Literature DB >> 19231922

Variation of mesenchymal cells in polylactic acid scaffold in an osteochondral repair model.

Yasushi Oshima1, Frederick L Harwood, Richard D Coutts, Toshikazu Kubo, David Amiel.   

Abstract

OBJECTIVE: To achieve osteochondral regeneration utilizing transplantation of cartilage-lineage cells and adequate scaffolds, it is essential to characterize the behavior of transplanted cells in the repair process. The objectives of this study were to elucidate the survival of mesenchymal cells (MCs). In a polylactic acid (PLA) scaffold and assess the possibility of MC/PLA constructs for osteochondral repair.
DESIGN: Bone marrow from mature male rabbits was cultured for 2 weeks, and fibroblast-like MCs, which contain mesenchymal stem cells (MSCs), were obtained. A cell/scaffold construct was prepared with one million MCs and a biodegradable PLA core using a rotator device. One week after culturing, the construct was transplanted into an osteochondral defect in the medial femoral condyle of female rabbits and the healing process examined histologically. To examine the survivability of transplanted MCs, the male-derived sex-determining region Y (SRY) gene was assessed as a marker of MCs in the defect by polymerase chain reaction (PCR).
RESULTS: In the groups of defects without any treatment, and the transplantation of PLA without cells, the defects were not repaired with hyaline cartilage. The cartilaginous matrix by safranin O staining and type II collagen by immunohistochemical staining were recognized, however the PLA matrix was still present in the defects at 24 weeks after transplantation of the construct. During the time passage, transplanted MCs numbers decreased from 7.8 x 105 at 1 week, to 3.5 x 105 at 4 weeks, and to 3.8 x 104 at 12 weeks. Transplanted MCs were not detectable at 24 weeks.
CONCLUSIONS: MCs contribute to the osteochondral repair expressing the cartilaginous matrix, however the number of MCs were decreasing with time (i.e. 24 weeks). These results could be essential for achieving cartilage regeneration by cell transplantation strategies with growth factors and/or gene therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19231922      PMCID: PMC2819711          DOI: 10.1089/ten.TEC.2008.0487

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  43 in total

1.  Expanded phenotypically stable chondrocytes persist in the repair tissue and contribute to cartilage matrix formation and structural integration in a goat model of autologous chondrocyte implantation.

Authors:  Francesco Dell'Accio; Johan Vanlauwe; Johan Bellemans; Johan Neys; Cosimo De Bari; Frank P Luyten
Journal:  J Orthop Res       Date:  2003-01       Impact factor: 3.494

2.  Repair of chronic osteochondral defects in the rat. A bone marrow-stimulating procedure enhanced by cultured allogenic bone marrow mesenchymal stromal cells.

Authors:  M Nishimori; M Deie; A Kanaya; H Exham; N Adachi; M Ochi
Journal:  J Bone Joint Surg Br       Date:  2006-09

3.  Repair of full-thickness cartilage defects with cells of different origin in a rabbit model.

Authors:  Hui Yan; Changlong Yu
Journal:  Arthroscopy       Date:  2007-02       Impact factor: 4.772

4.  Donor cell fate in tissue engineering for articular cartilage repair.

Authors:  R V Ostrander; R S Goomer; W L Tontz; M Khatod; F L Harwood; T M Maris; D Amiel
Journal:  Clin Orthop Relat Res       Date:  2001-08       Impact factor: 4.176

5.  Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees.

Authors:  S Wakitani; K Imoto; T Yamamoto; M Saito; N Murata; M Yoneda
Journal:  Osteoarthritis Cartilage       Date:  2002-03       Impact factor: 6.576

6.  Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects.

Authors:  Joseph Quintavalla; Susan Uziel-Fusi; Jianyun Yin; Ernst Boehnlein; Gary Pastor; Vincent Blancuzzi; Hem N Singh; Karl H Kraus; Elizabeth O'Byrne; Theodore C Pellas
Journal:  Biomaterials       Date:  2002-01       Impact factor: 12.479

Review 7.  Microfracture: surgical technique and rehabilitation to treat chondral defects.

Authors:  J R Steadman; W G Rodkey; J J Rodrigo
Journal:  Clin Orthop Relat Res       Date:  2001-10       Impact factor: 4.176

Review 8.  Mosaicplasty for the treatment of articular defects of the knee and ankle.

Authors:  L Hangody; P Feczkó; L Bartha; G Bodó; G Kish
Journal:  Clin Orthop Relat Res       Date:  2001-10       Impact factor: 4.176

9.  Repair of porcine articular osteochondral defects in non-weightbearing areas with autologous bone marrow stromal cells.

Authors:  Guangdong Zhou; Wei Liu; Lei Cui; Xiaoyun Wang; Tianyi Liu; Yilin Cao
Journal:  Tissue Eng       Date:  2006-11

10.  Polymer/alginate amalgam for cartilage-tissue engineering.

Authors:  E J Caterson; W J Li; L J Nesti; T Albert; K Danielson; R S Tuan
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

View more
  10 in total

1.  Survival of aging CD264+ and CD264- populations of human bone marrow mesenchymal stem cells is independent of colony-forming efficiency.

Authors:  Sean D Madsen; Sean H Jones; H Alan Tucker; Margaret K Giler; Dyllan C Muller; Carson T Discher; Katie C Russell; Georgina L Dobek; Mimi C Sammarco; Bruce A Bunnell; Kim C O'Connor
Journal:  Biotechnol Bioeng       Date:  2019-11-12       Impact factor: 4.530

2.  Oligo[poly(ethylene glycol)fumarate] hydrogel enhances osteochondral repair in porcine femoral condyle defects.

Authors:  James H Hui; Xiafei Ren; Mohd Hassan Afizah; Kerm Sin Chian; Antonios G Mikos
Journal:  Clin Orthop Relat Res       Date:  2013-04       Impact factor: 4.176

3.  Multifunctional nanoparticles for intracellular drug delivery and photoacoustic imaging of mesenchymal stem cells.

Authors:  Isaac M Adjei; Hao Yang; Glendon Plumton; Lorena Maldonado-Camargo; Jon Dobson; Carlos Rinaldi; Huabei Jiang; Blanka Sharma
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

4.  Reprogrammed Synovial Fluid-Derived Mesenchymal Stem/Stromal Cells Acquire Enhanced Therapeutic Potential for Articular Cartilage Repair.

Authors:  Brian E Walczak; Hongli Jiao; Ming-Song Lee; Wan-Ju Li
Journal:  Cartilage       Date:  2021-09-01       Impact factor: 3.117

Review 5.  Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs).

Authors:  Darwin J Prockop; Daniel J Kota; Nikolay Bazhanov; Roxanne L Reger
Journal:  J Cell Mol Med       Date:  2010-09       Impact factor: 5.310

6.  Development and characterisation of a decellularised bovine osteochondral biomaterial for cartilage repair.

Authors:  Hazel L Fermor; Serena L Russell; Sophie Williams; John Fisher; Eileen Ingham
Journal:  J Mater Sci Mater Med       Date:  2015-04-21       Impact factor: 3.896

7.  Tri-layered composite plug for the repair of osteochondral defects: in vivo study in sheep.

Authors:  Altug Yucekul; Deniz Ozdil; Nuri Hunkar Kutlu; Esra Erdemli; Halil Murat Aydin; Mahmut Nedim Doral
Journal:  J Tissue Eng       Date:  2017-04-13       Impact factor: 7.813

Review 8.  The use of mesenchymal stem cells for cartilage repair and regeneration: a systematic review.

Authors:  Andy Goldberg; Katrina Mitchell; Julian Soans; Louise Kim; Razi Zaidi
Journal:  J Orthop Surg Res       Date:  2017-03-09       Impact factor: 2.359

9.  Evaluation of different commercial hyaluronic acids as a vehicle for injection of human adipose-derived mesenchymal stem cells.

Authors:  Camila Cohen Kaleka; Eder Zucconi; Tierri da Silva Vieira; Mariane Secco; Mário Ferretti; Moisés Cohen
Journal:  Rev Bras Ortop       Date:  2018-08-02

10.  Machine learning to predict mesenchymal stem cell efficacy for cartilage repair.

Authors:  Yu Yang Fredrik Liu; Yin Lu; Steve Oh; Gareth J Conduit
Journal:  PLoS Comput Biol       Date:  2020-10-07       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.